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Abstract
Background
To be meaningful, a core outcome set (COS) should be relevant to all stakeholders including
patients and carers. This review aimed to explore the methods by which patients and carers
have been included as participants in COS development exercises and, in particular, the
use and reporting of qualitative methods.
Methods
In August 2015, a search of the Core Outcomes Measures in Effectiveness Trials (COMET)
database was undertaken to identify papers involving patients and carers in COS develop-
ment. Data were extracted to identify the data collection methods used in COS develop-
ment, the number of health professionals, patients and carers participating in these, and the
reported details of qualitative research undertaken.
Results
Fifty-nine papers reporting patient and carer participation were included in the review, ten of
which reported using qualitative methods. Although patients and carers participated in out-
come elicitation for inclusion in COS processes, health professionals tended to dominate
the prioritisation exercises. Of the ten qualitative papers, only three were reported as a clear
pre-designed part of a COS process. Qualitative data were collected using interviews, focus
groups or a combination of these. None of the qualitative papers reported an underpinning
methodological framework and details regarding data saturation, reflexivity and resource
use associated with data collection were often poorly reported. Five papers reported diffi-
culty in achieving a diverse sample of participants and two reported that a large and varied
range of outcomes were often identified by participants making subsequent rating and rank-
ing difficult.
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Conclusions
Consideration of the best way to include patients and carers throughout the COS develop-
ment process is needed. Additionally, further work is required to assess the potential role of
qualitative methods in COS, to explore the knowledge produced by different qualitative data
collection methods, and to evaluate the time and resources required to incorporate qualita-
tive methods into COS development.
Introduction
Clinical trials in health care provide important evidence of the efficacy and safety of interven-
tions and treatments [1], thereby informing future patient care, clinical guidelines and health
policy [2, 3]. The selection of outcomes to be measured and reported is an important part of
the trial design process. Historically, the selection of outcomes has usually been based on the
views of individual study teams informed by clinical and statistical considerations, and guided
by regulatory considerations [4–6]. This is problematic since outcomes that matter to key
stakeholders, including patients and carers, may be omitted. Furthermore, a wide variety of
outcomes may be measured and reported across trials in the same health area “making it diffi-
cult or impossible to synthesise the results of different studies” [6] (p1). The difference in out-
comes used across studies can also make it hard to detect reporting bias, where authors fail to
report all findings because of the desire to report only positive results [7]. Greater uniformity
in the reporting of outcomes and measures within a research area would help to facilitate the
comparison and synthesis of research findings [7, 8].
One potential solution to this problem is the use of core outcome sets (COS). A COS is an
agreed standardised set of outcomes to be measured and reported as a minimum in all trials in
a specific health related area [6]. If implemented, a COS may help to ensure that outcomes are
relevant to a range of stakeholders and will provide consistent trial outcome data to inform evi-
dence synthesis, clinical practice, shared-decision making and health policy [9, 10]. Stakehold-
ers can include patients, carers, patient representatives and patient advocates (reported as
patients and carers from this point onwards), as well as healthcare professionals and decision
makers including: funders, researchers, statisticians, health economists and pharmaceutical
company representatives (reported as health professionals from this point onwards) [4, 10].
Ultimately, it is the patients and those around them (carers) who benefit from improved
healthcare and so it is important that their views and preferences are heard, particularly as
there is evidence to suggest that patients’ perspectives may differ from those of clinicians [11].
Despite the potential benefits of including a wide range of stakeholders in COS develop-
ment, evidence to-date demonstrates that relatively few (18%) COS exercises include patients
and carers and the reporting of the process does not always make it clear how they have partic-
ipated [6]. Gargon et al. [6] recommended that further work is carried out to identify effective
methods of eliciting patient and carer views in outcome set development. Data generated
using qualitative methods can help to provide in-depth insight into patients’ and carers’ per-
spectives [12]. Therefore, qualitative methods could be well placed to identify outcomes that
are important to patients and carers and to understand why that is. The aim of this review was
therefore to: 1) review the methods by which patients and carers have been included as partici-
pants in COS development and 2) explore and describe the reported use of qualitative research
with patients and carers. For the purpose of this review we were interested in participation,
that is where patients and carers contribute data to COS development exercises as research
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participants, rather than involvement, where they contribute to the research process as an
active research partner or advisor.
Methods
Data source
The Core Outcome Measures in Effectiveness Trials (COMET) Initiative “aims to bring
together people interested in the development, reporting and promotion of COS, derived
using rigorous consensus methods” [4]. The COMET Initiative database is an international
repository of studies relevant to the development of COS, planned, ongoing and completed
[13]. The COMET database was developed based on a systematic review using extensive
searches [4] and the COMET Initiative conduct an annual search of the literature in order to
keep the database up to date [13]. In addition, planned and ongoing COS exercises can be sub-
mitted to COMET by individuals or groups for inclusion in the database [13].
Search strategy
Given that the COMET database is a comprehensive source for COS development studies with
the contents regularly updated, we limited our search to this one database.
COS Studies involving patient/carer involvement. The COMET database was searched
on the 13 August 2015 using the following search categories: Carer organisations / Support
group representatives, Charities, Conference participants, Consumers (caregivers), Consumers
(patients), Families, Individuals with a known interest, Patient / Support group representa-
tives, Service users, Guideline developers, with a study type of COS. Inclusion criteria were:
papers developing COS with patients and carers as research participants. In addition, reference
searches of the included papers were conducted.
Qualitative studies to inform COS development involving patients and carers. From
these searches we identified all papers that described research using qualitative data collection
methods (e.g. focus groups, interviews).
Data extraction and reporting
A data extraction pro-forma was developed, piloted and used to record study specific informa-
tion: title, author, year, location of study (country), health area and data collection dates. For
COS papers not using qualitative data collection methods we extracted the data collection
methods used and the number of health professionals and patient and carer representatives
participating in these. For papers reporting qualitative data collection methods we extracted;
the stated qualitative methodological framework and rationale for this (please note: in qualita-
tive research the methodological framework guiding research conduct, such as grounded the-
ory, phenomenology or ethnography is distinguished from the methods used during conduct
e.g. sampling, data collection, analytic approach) [14]; methods (sampling approach; data col-
lection and analysis); sample characteristics; resource use (costs, resources and time involved);
stated strengths and limitations and stated impact of the qualitative research). Some data items
were informed by the CASP Qualitative Checklist [15].
The lead author (JJ) extracted data from all included papers and a second researcher (JMM,
LLJ, MJC or TJHK) checked the extraction for accuracy on all papers reporting the use of qual-
itative methods. Any discrepancies were resolved via discussion within the research team.
Data extraction were combined when a COS development exercise was reported across more
than one paper. Data have been summarised descriptively. Recommendations have been made
for the transparent reporting of qualitative research to inform COS development.
Patient and carer involvement and qualitative research in core outcome set development
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Results
COS studies with patients and carers
Included papers. Of the 666 records on the COMET database, our initial search strategy
returned 149 papers (Fig 1). Seventy-three of the returned studies were unpublished, and of
the remaining 76, 24 were excluded because there were insufficient details to determine
whether they were reporting a COS including patients or carers. Through reference searches
of the included papers an additional seven papers [16–22] were identified as part of the
included COS development exercises. Of these, four [16, 19, 21, 22] were not archived on
COMET at the point of the final search and three [17, 18, 20] papers were not returned in the
initial search because they did not include patients or carers as participants; however, they
described part of a COS pathway which included patient or carers reported in a separate
publication.
Participants in the COS development. The 59 included papers represent a total of 34
COS development exercises covering 32 different health areas (Table 1). In 19 papers the num-
ber of participants was unclear.
The data collection methods used in COS development including patients and carers were;
Delphi exercises (n = 14), consensus conferences/meetings (n = 20), surveys (n = 10), inter-
views (n = 6), focus groups (n = 6), nominal group techniques (n = 9) and other (n = 5). For
the methods where participant numbers were reported fully, the mean percentage of patients
and carers in each ranged from 20% to 86% (Table 2). Patients and carers formed the majority
or all of the participants in surveys, interviews and focus groups. Health Professionals formed
the majority of participants in nominal group techniques, Delphi exercises and consensus
meetings. In all cases where qualitative data collection methods were utilised the primary aim
was to identify outcomes of importance to the participants.
Qualitative studies to inform COS development involving patients and
carers
Ten papers [16, 19, 21, 22, 24, 30, 32, 34, 35, 37] reported using qualitative data collection
methods to identify outcomes important to patients and carers (Table 3). However, of these
only three were clearly reported as part of a COS development process [16, 24, 30]; five dis-
cussed outcomes with patients and carers but it was unclear whether the data were collected
specifically with the intention to include them in a COS [21, 32, 34, 35, 37]; and two further
studies were conducted for other primary research aims, such as exploring perceptions of
access to care [19, 22].
Methodological framework. Of the papers reporting a qualitative approach in the devel-
opment of a COS [16, 19, 21, 22, 24, 30, 32, 34, 35, 37] none explicitly reported an underpin-
ning methodological framework.
Sampling. Eight papers [16, 19, 21, 22, 24, 30, 34, 35] reported using purposive sampling
and two [32, 37] did not discuss a clear sampling strategy. All papers gave details of participant
age, gender and some clinical detail (e.g. disease severity). However, some omitted details on
socio economic status [19, 21, 22, 24, 30, 32, 34, 35] and ethnicity [19, 21, 22, 30, 34, 35]. Nine
papers [16, 19, 22, 24, 30, 32, 34, 35, 37] recruited participants from a single country but one
paper [21] included participants from five different European countries.
Data collection. Four papers reported interviews with patients and carers as the only data
collection method [19, 30, 34, 35]. The number of interviews reported in these studies ranged
from 22 to 31. Focus groups were the only method reported in four papers: Arnold [24] and
Saketkoo [32] conducted six focus groups, Turk [37] four, and Stamm [21] ten. There was an
Patient and carer involvement and qualitative research in core outcome set development
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Fig 1. Flow diagram of paper identification and inclusion process.
https://doi.org/10.1371/journal.pone.0172937.g001
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Table 1. Summary of included papers.
Reference Publication
year
Health area Ethics committee
approval obtained
Data collection
methods
Health
Professionals (n)
Patients
(n)
Carers and/or
representatives (n)
Core outcome set development exercises using qualitative methods with patients, carers and representatives
Allard et al [16]α 2014 Neurodisability Not stated Focus groups 0 50 47
Interviews 0 4 6
Janssens [17]
et alα
2014 Neurodisability Not stated Delphi 233 0 0
Morris et al [23]
et al
2015 Neurodisability Not stated OtherΩ 7 3 5
Arnold et al [24] 2008 Fibromyalgia Yes Focus groups 0 48 0
Mease et al [25] 2008 Fibromyalgia Yes Delphi 23 100 0
Mease et al [26] 2007 Fibromyalgia Yes Consensus
meeting
Not stated Not stated 0
Mease et al [27] 2009 Fibromyalgia Not stated Consensus
conference
Not stated Not stated 0
Stamm et al [21]α 2009 Osteoarthritis Yes Focus groups 0 56 0
Kloppenburg et al
[28]
2014 Osteoarthritis Not stated Delphi 31 0 0
OtherΩ Not stated Not stated 0
Potter et al [19]απ 2013 Breast cancer Yes Interviews 35 31 0
Potter et a [20]α 2014 Breast cancer Yes Interviews 35 0 0
Potter et al [29] 2015 Breast cancer Yes Delphi 88 215 0
Consensus
meeting
23 15 0
Sanderson et al
[30]
2010a Rheumatoid arthritis Yes Interviews 0 23 0
Sanderson et al
[31]
2010b Rheumatoid arthritis Yes Nominal group
technique
0 26 0
Survey 0 254 0
Swigris et al [22]α 2005 Interstitial lung disease
(IPF)
Yes Interviews 0 5 0
Focus groups 0 15 0
Saketkoo et al [32] 2014a Interstitial lung disease
(CTD)
Yes Focus groups 0 45 0
Delphi 254 0 0
Saketkoo et al [33] 2014b Interstitial lung disease
(CTD)
Yes Nominal group
technique
23 5 0
Tierney et al [34] 2013 Cleft palate, otitis media Yes Interviews 0 0 43
Tierney et al [35]¥ 2015 Cleft palate, otitis media Yes Interviews 0 22 43π
Harman et al [36] 2015 Cleft palate, otitis media Yes Survey 0 8 35
Delphi 104 0 0
Consensus
meeting
11 0 5
Follow-up
workshop
1 0 9
Turk et al [37] 2008 Chronic pain Yes Focus groups 0 31 0
Survey 0 959 0
Core outcome set development exercises using other methods
Bellm et al [38] 2002 Oral mucositis Not stated OtherΩ 9 2 0
Bennett et al [39] 2012 Gestational diabetes
mellitus
Not stated Survey 4 0 2
Consensus
meeting
4 0 2
Delphi 7 0 2
Online evaluation Not stated 0 Not stated
Broder et al [40] 2000 Uterine fibroids Not stated Delphi 9 0 1
Nominal group
technique
10 0 1
Buch et al [41] 2015 Rheumatic diseases Not stated OtherΩ 20 2 0
Delphi 20 1 0
(Continued)
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Table 1. (Continued)
Reference Publication
year
Health area Ethics committee
approval obtained
Data collection
methods
Health
Professionals (n)
Patients
(n)
Carers and/or
representatives (n)
Carlson et al [42] 2003 Mania/Bipolar disorder Not stated Consensus
conference
53 0 Not stated
Chiarotto et al [43] 2015 Lower back pain Exempt Delphi 129 14 0
Chitnis et al [44] 2012 Multiple Sclerosis Not stated Survey 51 0 Not stated
Chitnis et al [45] 2013 Multiple Sclerosis Not stated Consensus
meeting
69 0 Not stated
Survey Not stated 0 0
Devane et al [5] 2007 Maternity care Yes Delphi 194 9 15
Gladman et al [46] 2005 Psoriatic arthritis Not stated Nominal group
technique
Not stated Not stated 0
Gladman et al [47] 2007 Psoriatic arthritis Not stated Consensus
meeting
Not stated* Not
stated*
0
Goldhahn et al
[48]
2014 Distal radius fracture Not stated Nominal group
technique
Not stated0 Not
stated0
0
Gonzalez et al
[49]
2011 Vitiligo Not stated Consensus
meeting
Not stated Not stated 0
Eleftheriadou et al
[50]
2012 Vitiligo Yes Survey Not stated Not
statedΨ
0
Eleftheriadou et al
[51]
2015 Vitiligo Not stated Delphi 69 32 0
Haeusler et al [52] 2015 Febrile neutropenia Not stated Delphi 39 4 0
Haywood et al [53] 2014 Hip fracture Not stated Survey 13 1 3
Nominal group
technique
22 0 3
Karas [54] 2015 Acute diarrhoea Not stated Delphi 70 0 31
Katona et al [55] 2007 Dementia Not stated Consensus
conference
33 0 3
Merkies et al [56] 2006 Peripheral neuropathy Not stated Consensus
conference
22 1 0
Moniz-Cook et al
[57]
2008 Dementia care Not stated Consensus
meeting
Not stated 0 0
Survey 131 0 5
Consensus
meeting
Not stated 0 0
Consensus
meeting
Not stated 0 0
Reilly et al [58] 2006 Charcot-Marie-Tooth
disease type 1A
Not stated Consensus
conference
21 2 0
Salaffi et al [59] 2012 Fibromyalgia Yes Delphi 252 86 0
Schmitt et al [60] 2007 Eczema Not stated Survey 6 4 2
Schmitt et al [61] 2010 Eczema Not stated Consensus
conference
Not stated# Not
stated#
Not stated#
Schmitt et al [62] 2011 Eczema Not stated Delphi 40 6 0
Schmitt et al [63] 2012 Eczema Not stated Nominal group
technique
38 5 0
Sinha et al [64] 2012 Asthma Yes Delphi 46 0 0
Survey 0 11 88
Stuart et al [65] 2011 Ovarian cancer Not stated Consensus
conference
Not stated 0 Not stated
Thigpen et al [66] 2011 Ovarian cancer Not stated Consensus
conference
Not stated 0 Not stated
Tugwell et al [67] 1993 Rheumatoid arthritis Not stated Consensus
conference
Not stated Not stated Not stated
Nominal group
technique
Not stated Not stated Not stated
(Continued)
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average of seven participants per group. A combination of interviews and focus groups were
reported in two papers; Allard [16] who carried out ten individual interviews and 12 focus
groups (97 participants) and Swigris [22] who conducted five individual interviews and three
focus groups (15 participants).
All studies were audio-recorded and transcribed verbatim, and all reported using topic or
discussion guides. However, only four [16, 19, 30, 34] provided details of the contents or deri-
vation of these.
Table 1. (Continued)
Reference Publication
year
Health area Ethics committee
approval obtained
Data collection
methods
Health
Professionals (n)
Patients
(n)
Carers and/or
representatives (n)
Kirwan et al [68] 2003 Rheumatoid arthritis Not stated Consensus
conference
46 11 0
Kirwan et al [69] 2005 Rheumatoid arthritis Not stated Consensus
conference
160 19 0
Kirwan et al [70] 2007 Rheumatoid arthritis Not stated Consensus
conference
60 20 0
Van der Heijde
et al [71]
1997 Ankylosing spondylitis Not stated OtherΩ Not stated Not stated 0
Nominal group
technique
Not stated Not stated 0
Vargus-Adams
et al [72]
2009 Cerebral palsy Yes Delphi 39 21 23
MacKichen et al
[18]α
2015 Chronic pain after total
knee replacement
Not stated Focus groups 18 0 0
Wylde et el [73] 2015 Chronic pain after total
knee replacement
Yes Delphi 39 71 0
Consensus
meeting
Not stated 12 0
*total number of participants = 137, breakdown not provided.
0 total number of participants = 26, breakdown not provided.
#total number of participants = 40, breakdown not provided.
Ψ total number of participants = 461, breakdown not provided.
α Papers not in original search, included because they are part of the COS pathway.
¥ Full details given in Tierney 2013.
Ω Other = meetings/semi-structured discussions.
Papers in italics have a qualitative component which was carried out prior to the COS exercise and was not specifically designed for the COS work but has
fed into it.
Not Stated = participants in stakeholder group implied by numbers not given.
N.B. Papers grouped together are part of the same COS exercise.
https://doi.org/10.1371/journal.pone.0172937.t001
Table 2. Mean percentage of Health professionals to patients and carers by data collection method.
Method Health Professionals (mean
%)
Patients and carers (mean
%)
Consensus meetings/conferences
(n = 9)
80 20
Delphi (n = 19) 77 23
Nominal group technique (n = 5) 70 30
Surveys (n = 8) 36 64
Interviews (n = 7) 22 78
Focus groups (n = 7) 14 86
N.B. not all papers provided a full breakdown of participants and are therefore not included.
https://doi.org/10.1371/journal.pone.0172937.t002
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Table 3. Reporting of qualitative methods with patients and carers.
Allard 2014
[16]
Arnold 2008
[24]
Potter
2013 [19]
Saketkoo
2014a [32]
Swigris
2005 [22]
Stamm 2009
[21]
Sanderson
2010a [30]
Tierney
2013 [34]
Tierney
2015 [35]
Turk
2008
[37]
Health area Neurodisability Fibromyalgia Breast
cancer
Interstitial
lung
disease
Interstitial
lung
disease
Osteoarthritis Rheumatoid
arthritis
Cleft
palate,
otitis
media
Cleft
palate,
otitis
media
Chronic
pain
Theoretical
framework
N/R N/R N/R N/R N/R N/R N/R N/R N/R N/R
Sampling
Approach Purposive Purposive Purposive N/R# Purposive Purposive Purposive Purposive Purposive N/R#
No. approached N/R N/R N/R N/R N/R N/R N/R N/R N/R N/R
No. taking part 107 48 31 45 20 56 23 43 22 31
Age Yes Yes Yes YesΨ Yes Yes Yes Yes Yes Yes
Gender Yes Yes Yes YesΨ Yes Yes Yes Yes Yes Yes
Ethnicity Yes Yes N/R YesΨ N/R N/R N/R N/R N/R Yes
Socio economic
status
Yes N/R N/R N/R N/R N/R N/R N/R N/R Yes
Clinically
relevant info
Yes Yes Yes YesΨ Yes Yes Yes Yes Yes Yes
Data collection
Focus groups Yes Yes n/a Yes Yes Yes n/a n/a n/a Yes
Interviews Yes n/a Yes n/a Yes n/a Yes Yes Yes n/a
Data analysis
A priori
categories
applied
Yes (plus
emergent
themes)
No No No No No No No No No
Thematic/
content
analysis*
Yes n/a n/a Yes Yes Yes n/a Yes Yes Yes
Grounded
theory**
No Yes Yes No No No Yes No No No
Framework
approach***
Yes No No No No No Yes Yes Yes No
Data saturation
mentioned
Yes No Yes No Yes No Yes No No No
Triangulation
Multiple coders/
perspectives
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Data collection
methods (both
focus groups
and interviews)
Yes No No No Yes No No No Yes No
Reflexivity No Yes Yes No No No No No No No
N/R = not reported, n/a = not applicable,
#
= Some indication of types of participant included but not the sampling approach used.
Ψ Details reported in Saketkoo 2014b.
* Paper describes a generic thematic / content approach
** Paper describes analysis informed by Grounded Theory approaches, rather than an explicit Grounded Theory methodological framework
*** Paper refers to the use of framework as part of the analytical process
https://doi.org/10.1371/journal.pone.0172937.t003
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Data analysis. Only one of the papers [16] reported the use of a priori categories in the
analysis, with most using exclusively inductive data-driven approaches. Seven papers [16, 21,
22, 32, 34, 35, 37] reported using thematic or content analysis. Arnold [24], Potter [19] and
Sanderson [30] reported analysis based upon the principles of grounded theory. Four papers
also referred to the use of the framework approach in the analytical description [16, 30, 34, 35].
Four interview studies reported reaching data saturation [16, 19, 22, 30]. In two cases, satu-
ration was judged in conjunction with focus group data [16, 22]. None of the papers reporting
on focus groups only [21, 24, 32, 37] described achieving data saturation.
Triangulation. Data were analysed using multiple coders of and/or perspectives on the
data in all of the included papers. Three [16, 22, 35] reported on the triangulation [74] of two
different data collection methods (interviews and focus groups).
Reflexivity. Only two papers [19, 24] included any reflexive content. Potter [19] reported
the use of a medically trained interviewer and reflected on the influence this may have had on
the results. Arnold [24] discussed the use of an experienced facilitator with no prior knowledge
of the condition under investigation, to avoid leading discussions.
Reported strengths and limitations. All studies acknowledged some strengths and limi-
tations of their work. The main limitation noted in the included papers concerned recruit-
ment. Five papers reported on the difficulty in recruiting an ethnically diverse and gender
balanced sample [16, 24, 30, 33, 34]. Four discussed that they were unable to recruit partici-
pants to fulfil the desired sampling quota, for example, with not all categories of the disease/
investigation under investigation being included [16, 24, 30, 37].
Sanderson [31] and Turk [37] reported that patients and carers identified a rather large and
varied range of outcomes important to them, making subsequent rating and ranking very diffi-
cult. Potter [19] and Tierney [34] also highlighted the difficulty that participants may have
when asked to recall their treatments and experience.
The participation of patients and carers in the core outcome set process was identified as a
strength in 3 papers. Allard [16] stated that the differences between patients and parents were
highlighted, and Sanderson [30] and Saketkoo [32] both reported that outcomes identified by
patients and carers as important to them were not in current professional core outcome sets.
Resource use associated with qualitative methodology. Other than details on the length
of the focus groups and interviews and reimbursements, very little information about the
resources required to carry out qualitative data collection methods in COS development was
reported in the included papers.
Planned and ongoing studies. As of 13 August 2015, 73 studies (S1 appendix) were regis-
tered on the COMET database as planned or ongoing COS development studies. Of these, all
studies reported that they intended to include patients and carers as participants and 37 (52%)
stated they wouldbe using qualitative methods as part of the COS pathway (S2 appendix). Of
these 37, 21 planned to use both interviews and focus groups. Of the planned and ongoing
studies five have published protocols [75–79]. Overall this supports the findings in Gorst’s [80]
recently updated systematic review which reports the increase in COS development studies
and the increasing involvement of patients and carers.
Discussion
This study has described the different data collection methods used by COS developers in
order to elicit patient and carer views on their preferred treatment outcomes, and has focused
specifically on the reported use of methodology and methods within associated qualitative
research. To our knowledge it is the first review to focus specifically on the use and reporting
of qualitative research in COS development to date.
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We have used the COMET database to identify COS studies. The database is based upon a
systematic review of relevant studies and is regularly updated to ensure that new studies are
added as they become available [4]. However, it is possible that there may be a lag time before
studies are added to the database, or that COS relevant studies are not indexed or reported in
ways that would mean they are captured within the database. We did perform reference
searches of papers identified and found additional studies via this method. Therefore whilst
the COMET database is an appropriate source of COS studies based on systematic review
methodology, there is a possibility that there may be additional relevant studies not captured
here. Furthermore, the focus of this review has been on participation in COS exercises. That is,
we were concerned with the participation of patients and carers as research participants con-
tributing data to the development of COSs. Of course patients and carers can also contribute
to COS development via involvement in the research process as research partners and advi-
sors, and in doing so influence the research and outputs. Our review has not focused on this
involvement, which may not always be well reported and detailed in the outputs of COS stud-
ies. Further work to examine patient and carer involvement and its contribution to COS devel-
opment would be useful. Recent work focused on patient and carer involvement demonstrates
that this is a key issue that should be considered by researchers in the field [81].
To date, patients have participated in exercises that both identify relevant outcome domains
for consideration in a COS, such as interviews, focus groups, and surveys, and also in the
prioritisation and consensus methods that finalise a COS. However, the number and types of
participants taking part in these, particularly patients and carers, were sometimes difficult to
discern from the papers included in this review. Where participant numbers were reported,
proportionately more patients participated in methods designed to identify relevant outcome
domains for consideration, whilst Health Professionals were represented more than patients in
prioritisation and consensus methods.
In this sample, qualitative and survey approaches have included patients more than Health
Professionals to identify outcome domains. These methods may help incorporate patient per-
spectives that might otherwise go unheard, via the inclusion of patient preferred outcome
domains in subsequent prioritisation and consensus methods. However, in prioritisation exer-
cises (primarily Delphi methods in COS to date) where participant perspectives are aggregated
and quantified then absolute numbers of participants from different stakeholder groups will
influence outputs, particularly where views differ substantially between patients and carers
and other stakeholder groups. Our observation that patients appear to be in the minority in
these methods should be cause for reflection, although even if the number of participants from
different stakeholder groups were balanced, there is some evidence to suggest that patients and
carers rate many or all outcome domains as important in such exercises [31, 37]. If this were
the case then other stakeholder views may dominate as the outcome domains they do not
value, on aggregate, will not be taken forward to the final COS. The inclusion of qualitative
research to incorporate patient and carer perspectives as a precursor to group consensus
approaches will not necessarily guarantee that patients’ views are taken forward to the final
COS.
In consensus meetings and conferences, one might expect Health Professionals to have
more representation, as demonstrated here. The impact of patients and carers on outputs in
these circumstances may well depend on the process and means by which their views are facili-
tated and accommodated, and on who takes part [81], as much as absolute numbers present
versus other stakeholder groups.
Interestingly, one of the COS exercises we identified was expressly focused on understand-
ing patient views and developing a patient core outcome set [30], building on the OMERACT
work in rheumatoid arthritis. This approach does not rely on the integration of Health
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Professional and patient and carer views in a single COS exercise. Rather, it explicitly acknowl-
edges that patient views are likely to be different to those of other stakeholders and therefore
need specific consideration.
All of the qualitative research reviewed here was utilised as a means to ensure that patient
and carer perspectives on outcome domains were accommodated in COS development pro-
cesses. However, a key observation from this review is that some of this research (2 out of 10
papers) appear to have been designed and conducted for other primary research aims, not
associated with COS development. Exceptions to this are Sanderson [30], Allard [16] and
Arnold [24]. The remaining five papers [21, 32, 34, 35, 37] discussed outcomes with patients
and carers but it is unclear whether the information was collected specifically with the inten-
tion to include it in a COS exercise. The availability of related research which is ready to feed
into COS development, and the desire to include patient perspectives when specific COS-
focused primary qualitative work is potentially time and resource intensive, could explain this.
However, it does raise questions about the precise applicability of the underpinning qualitative
research.
None of the papers stated a clear overarching qualitative methodological framework. Three
[19, 24, 30] mentioned Grounded Theory, but only in descriptions of analytical approach. This
may well be perfectly justifiable, for example if COS related qualitative research is being under-
taken from an overtly generic qualitative research standpoint [82, 83], though to date there
does not appear to have been any reflection on this in the primary COS papers, or the COS
methodological literature. There are longstanding debates within the qualitative methodologi-
cal literature [82, 83] about the use of methodological frameworks (e.g. grounded theory, phe-
nomenology, ethnography), the coherency of underpinning research methods, and suitability
for specific research aims. These have generally been in response to generic qualitative
approaches that mix and match research methods, and which are more common in health-
related research.
Reflection on methodology may help to further define the purpose and role of qualitative
research in COS development. For example, if the primary aim is to understand and explain
patients’ perspectives as a means to influence COS development then an approach such as
Grounded Theory may be appropriate; if one argues that the lived experience of illness and
treatment is of chief concern as it describes the essence of disease experience which we are try-
ing to improve via trial research then a phenomenological framework may be informative; or
if we are simply wanting a pragmatic precursor that lists ‘patient priorities’ from descriptive
accounts prior to COS prioritisation exercises, then forms of generic descriptive qualitative
research may suffice. Whilst to our knowledge these issues have not been considered in COS
research, suitable methodological frameworks have been discussed in analogous outcome
related work in the patient reported outcome development literature concerning content valid-
ity [84]. It would seem that there are very clear parallels between this work and COS qualitative
research.
Thinking about data collection methods specifically, this review demonstrates the use of
interviews, focus groups, and a combination of these. Whilst there has been some recent atten-
tion to this in the methodological literature [85] empirical comparisons of the outputs and
relative merits of different methods is needed in this developing area. Some of this work is cur-
rently underway (S3 appendix).
The qualitative papers reviewed note limitations around recruitment and diversity of sam-
ples. The reporting of sample characteristics is also variable. This is important when consider-
ing the generalisability (transferability in qualitative terms) of findings. Implicitly, COS
development for trials assumes the generalisability of the final COS to varied populations and
settings [81]. Conversely, qualitative approaches may not necessarily lay claim to widespread
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generalisability, acknowledging that patients’ and carers’ perspectives may vary, for example,
in time, place and according to cultural factors. In addition to clear reporting of sample char-
acteristics to aid judgements of transferability this issue needs acknowledgment. This has been
addressed in some COS work, for example with work to culturally validate a patient core set
amongst non-white patients in rheumatoid arthritis [86]. Outcomes and their importance in
health research is often a difficult concept for patients and carers to understand [16, 85]. The
data collection methods used may have a direct impact on the depth of explanation of out-
comes required [81]. For example, qualitative methods allow participants to talk about their
experiences of illness without the need for an in-depth understanding of outcomes [87]. There
is currently no guidance on how to discuss outcomes with patients and carers in qualitative
research. The sharing of best practice and the publication of topic guides will aid future COS
work [81, 85].
There are some fairly simple reporting recommendations (Table 4) that we would make for
future qualitative COS work which include: clear reporting of aims in relation to the COS
development; sampling and sample characteristics; data collection methods and derivation;
use and reporting of the topic guide; data analysis; overt description of findings in the context
of the COS; and reflection on strengths and limitations of approach. Beyond this we would
suggest that there is a need for more fundamental consideration of the role of qualitative meth-
ods in COS and related methodological approaches, of the relative merits of different data col-
lection approaches in terms of knowledge produced and time and resource requirements, as
well as claims to generalisability.
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